3. Microbial target index
Reverse view — the 196 foods organized by the eight most important microbial targets, ranked by level of evidence.
The Food Sources v1.5 book provides a per-food, in-depth description across its 196 chapters. This appendix offers the reverse view: it organizes the foods by microbial targets. A clinician, dietitian or donor-diet planner can thus get a quick answer to the question of which chapters contain the best foods for achieving a given target.
The appendix presents eight ranked lists by target. Only those foods are included for which the Food Sources v1.5 references contain at least moderate-strength evidence (★★). Entries at the ★ level (preclinical / hypothetical only) and empty cells are omitted — for the sake of credibility.
| Notation | Interpretation |
|---|---|
| ★★★ | Strong human evidence: at least 1 RCT or meta-analysis with direct microbiome measurements |
| ★★ | Moderate evidence: human pilot + mechanistic rationale + in vitro fermentation + epidemiological association |
| ⚠ | Risk category: control or dosing required (not an absolute contraindication) |
The ★ and empty rows are omitted. The full 196-chapter evidence matrix is detailed within the individual chapters of the book.
What does it target? Fructan, FOS, GOS, inulin prebiotics → selective increase in the Bifidobacterium proportion in the colon.
★★★ — Strong human RCT evidence:
| Chapter | Evidence |
|---|---|
| I.1 Artichoke | Costabile 2010 Br J Nutr — human RCT with very-long-chain inulin |
| I.3 Asparagus | Tang 2015 human mid-FOS intake + EFSA inulin claim |
| I.4 Chicory | Link + Kolida 2002 Br J Nutr |
| I.14 Jerusalem artichoke | Bonnema 2010 J Am Diet Assoc + Tuohy 2001 human inulin RCT |
| XIII.4 Agave inulin | Ramnani 2015 J Nutr Sci + Camacho-Díaz 2023 Nutrients IBS-C RCT |
★★ — Moderate evidence:
| Chapter | Evidence |
|---|---|
| I.5 Onion | Tang 2015 human mid-FOS association |
| I.6 Garlic | Sun 2017 human pilot + epidemiology |
| I.7 Leek | FOS content + epidemiology |
| II.1 Lentil | GOS content + Bazzano 2011 meta + human intervention |
| II.2 Chickpea | Fiber prebiotic + human legume-consumption meta |
| II.3 Bean | Galactomannan fiber + epidemiology |
| II.4 Green pea / pea fiber | Human fiber-prebiotic pilots |
| III.2 Almond | Liu 2014 human RCT J Funct Foods |
| IV.1 Apple | Cuervo 2014 human pilot + pectin |
| IV.7 Green banana | Bhattacharyya 2016 human RS2 pilot |
| V.2 Date | Eid 2014 in vitro + Eid 2015 human pilot |
| X.4 Chicory coffee | Chicory inulin residue + Slavin meta |
| X.10 Chicory root tea | Cherbut 2002 + Kolida 2007 5—8 g inulin human |
| XIII.1 Psyllium | Jalanka 2019 Sci Rep human + F. prausnitzii increase |
| XIII.3 Gum arabic | Calame 2008 Br J Nutr human RCT |
What does it target? Intake of live Lactobacillus / Lactiplantibacillus / lactic acid bacteria via fermented carriers.
★★★ — Strong human RCT evidence:
| Chapter | Evidence |
|---|---|
| VIII.1 Sauerkraut | Wastyk 2021 Cell 10-week fermented-food portfolio RCT |
| VIII.3 Kimchi | Han 2015 Mol Nutr Food Res + Kim 2022 IBS RCT |
| IX.1 Yogurt | EFSA 2010 lactose-digestion claim + Marteau 2002 Aliment Pharmacol Ther DN-173 010 |
| IX.2 Kefir | Bellikci-Koyu 2019 Nutrients metabolic syndrome RCT + Wastyk 2021 |
★★ — Moderate evidence:
| Chapter | Evidence |
|---|---|
| VIII.2 Brined cucumber | Extrapolated from the Wastyk portfolio |
| VIII.4 Miso | Inoue 2021 Nutrients 14-day human intervention |
| VIII.8 Fermented mixed vegetables | Extrapolated from the Wastyk portfolio |
| IX.3 Aged cheeses | Sharp 2008 J Dairy Sci probiotic Gouda elderly RCT |
| XV.28 Kombucha | Wastyk 2021 portfolio + Stiemsma 2020 J Nutr review |
What does it target? Polyphenols, ellagitannins, anthocyanins → support of the Akkermansia muciniphila mucin matrix.
★★★ — Strong human RCT evidence:
| Chapter | Evidence |
|---|---|
| IV.4 Pomegranate | Henning 2017 Eur J Nutr + Cortés-Martín 2018 Front Microbiol ellagitannin–Akkermansia human RCT |
| X.1 Green tea / Matcha | Link + Liu 2022 Crit Rev Food Sci Nutr review |
| XVI.1 Cacao / dark chocolate | Tzounis 2011 AJCN + COSMOS trial Sesso 2022 AJCN (n≈21,000) |
★★ — Moderate evidence:
| Chapter | Evidence |
|---|---|
| III.1 Walnut | Holscher 2018 J Nutr human microbiome RCT |
| III.3 Pistachio | Ukhanova 2014 Br J Nutr human RCT + Bifidobacterium increase |
| IV.5 Grape | Roopchand 2015 Diabetes + Most 2017 AJCN human pilot |
| IV.11 Blackcurrant | Wallace 2016 Crit Rev Food Sci Nutr meta-analysis on anthocyanins |
| IV.12 Cranberry | Anhê 2015 Gut animal + Rodríguez-Morató 2018 human pilot |
| IV.13 Black chokeberry (aronia) | Le Sayec 2022 Mol Nutr Food Res human RCT on anthocyanins |
| IV.14 Blueberry | Vendrame 2011 J Agric Food Chem + Lacombe 2013 J Funct Foods human |
| VII.17 Black rice | Czank 2013 AJCN cyanidin-3-glucoside metabolism + Wallace 2016 |
| X.2 Black tea | Mou 2018 Food Funct human RCT Prevotella + theaflavin |
| X.3 Coffee | Jaquet 2009 Int J Food Microbiol + Asnicar 2024 Nat Med (n>22,000) |
| X.5 Pu-erh tea | Hou 2021 mSystems human microbiome module |
| XI.1 Extra virgin olive oil | Marcelino 2019 Front Nutr review + Carnevale 2017 human pilot |
| XII.2 Mussel / oyster | Link — diet–microbiome association |
| XV.1 Turmeric | Scazzocchio 2020 Nutrients mechanistic + human microbiome module |
| XV.6 Chili / capsaicin | Kang 2017 mBio + Bonaccio 2019 JACC CV epidemiology |
| XIX.1 Broccoli sprout | Egner 2011 Cancer Prev Res sulforaphane bioavailability human RCT |
What does it target? Roseburia, Faecalibacterium prausnitzii, Eubacterium rectale SCFA substrates.
★★★ — Strong human RCT evidence:
| Chapter | Evidence |
|---|---|
| VII.1 Oats | Connolly 2016 J Funct Foods + EFSA β-glucan claim + butyrate fermentation human |
| VII.14 Resistant starch RS2 | Maki 2012 J Nutr + Walker 2011 ISME J + Bodinham 2014 Endocr Connect + Li 2024 Nat Metab |
| XIII.1 Psyllium | Jalanka 2019 Sci Rep — selective F. prausnitzii increase + serum butyrate increase |
★★ — Moderate evidence:
| Chapter | Evidence |
|---|---|
| I.1 Artichoke | Inulin fermentation (secondary colonic butyrate) |
| I.3 Asparagus | Inulin fermentation |
| I.4 Chicory | Inulin fermentation |
| I.14 Jerusalem artichoke | Inulin fermentation |
| II.1 Lentil | Galactomannan + GOS human fermentation |
| II.2 Chickpea | Galactomannan + GOS |
| II.3 Bean | Galactomannan fermentation human |
| III.7 Flaxseed | Hu 2019 human + lignan-mediated microbiome module |
| IV.7 Green banana | Bhattacharyya 2016 human RS2 pilot |
| V.1 Prune | Lever 2014 Clin Nutr + Hooshmand 2022 human |
| VII.2 Barley | De Angelis 2015 Appl Environ Microbiol + Aoe 2017 Nutrients |
| VII.3 Rye | Vuholm 2018 J Nutr + Eriksen 2020 Br J Nutr human crossover |
| VII.4 Wheat | Costabile 2008 Br J Nutr AXOS human RCT |
| VII.7 Corn | Whisner 2016 J Nutr + Van den Abbeele 2018 Br J Nutr human |
| VII.15 Resistant starch RS3 | Sonia 2015 APJCN + Patterson 2020 J Acad Nutr Diet |
What does it target? Bacteroidetes-mediated propionate production → GLP-1, PYY, appetite regulation, reduction of liver fat.
The human propionate-specific RCT evidence is more modest than for butyrate — therefore there is no ★★★ rating here. Propionate always appears in a butyrate + propionate matrix in human fermentation studies.
★★ — Moderate evidence:
| Chapter | Evidence |
|---|---|
| VII.1 Oats | Wolever 2010 AJCN — β-glucan + propionate human fermentation |
| VII.2 Barley | β-glucan + propionate human fermentation |
| II.1 Lentil | Galactomannan + Bazzano 2011 lipid meta (indirect) |
| II.4 Green pea / pea fiber | Lupin/pea fiber prebiotic + human pilot |
| II.5 Lupin seed / lupin fiber | Lupin fiber specific propionate fermentation human |
| XIII.1 Psyllium | Gibb 2015 AJCN meta + propionate fermentation |
| IV.1 Apple | Pectin → propionate fermentation human |
What does it target? Dietary nitrate → Veillonella / Rothia / oral commensals nitrate reduction → nitrite → systemic NO → blood pressure, vascular function, athletic performance.
★★★ — Strong human RCT evidence:
| Chapter | Evidence |
|---|---|
| I.11 Beetroot | Link + Velmurugan 2016 AJCN human hypertension RCT |
| I.18 Spinach | Bondonno 2016 nitrate-rich vegetables + flow-mediated dilation human |
★★ — Moderate evidence:
| Chapter | Evidence |
|---|---|
| I.8 Cruciferous vegetables | Moderate nitrate + Bondonno portfolio |
| I.13 Radish | Nitrate content + human pilot studies |
What does it indicate? Bilophila wadsworthia proliferates with high animal fat (especially saturated) + high taurine-conjugated bile-acid intake. A chronically high proportion is pro-inflammatory and colitis-associated. A risk requiring control, not an absolute contraindication.
⚠ — Risk category (each is high animal fat or high SFA):
| Chapter | Evidence |
|---|---|
| XI.2 Butter | Saturated fat + Astrup 2020 AJCN matrix-hypothesis context |
| XI.3 Ghee | More concentrated saturated fat (≈ 60 g SFA / 100 g) |
| XI.6 Coconut oil | 82—92% SFA + Sacks 2017 Circulation AHA advisory |
| XII.1 Fatty marine fish | High total fat matrix consideration (context-sensitive) |
| XII.5 Herring | High fat |
| XII.6 Sardine | High fat + Mortensen 2014 Q-SYMBIO context |
| XII.7 Tuna (fatty species) | High fat + mercury dual risk |
| XII.8 Salmon | High fat (context-sensitive) |
| XII.10 Mackerel | High fat |
| XII.13 Eel | High fat (≈ 18 g/100 g) + retinol stringency |
| XVII.1 Chicken egg | Cholesterol + choline-TMAO microbiome pathway — context-sensitive |
| XVII.4 Duck / goose egg | Higher cholesterol (≈ 850 mg/100 g) |
| IX.3 Aged cheeses | Saturated fat + tyramine combined risk |
What does it indicate? High fructan, GOS, raffinose, fructose or sorbitol is the gas-producing substrate of Methanobrevibacter smithii + Methanosphaera. In IBS- / SIBO-sensitive individuals it causes symptomatic worsening. It can be dosed (5—10 g/day start, titration), but control is required.
⚠ — Risk category (high FODMAP / fermentable substrate):
| Chapter | Evidence |
|---|---|
| I.1 Artichoke | High fructan (Monash red) |
| I.3 Asparagus | Fructan + raffinose |
| I.4 Chicory | Inulin (12 g already at the IBS-symptom threshold) |
| I.5 Onion | Fructan Monash red |
| I.6 Garlic | Fructan Monash red |
| I.7 Leek | Fructan red |
| I.14 Jerusalem artichoke | Inulin (one of the highest natural sources) |
| II.1 Lentil | GOS + raffinose |
| II.2 Chickpea | GOS + raffinose |
| II.3 Bean | GOS + raffinose Monash red |
| IV.19 Fresh fig | High fructose |
| V.1 Prune | Sorbitol + fructose concentrate |
| V.2 Date | High fructose + glucose |
| V.3 Raisin | High fructose + glucose concentrate |
| XIII.4 Agave inulin | Branched fructan Monash red (12 g/day → IBS symptom) |
Clinical decision-making: Choose a target (e.g. "strong Akkermansia support"), look up the ★★★ list, and from there every food is ranked, with evidence. The contraindication matrix (Appendix B) can further filter for an individual patient.
Donor-diet planning: For weekly rotation, choose 2—3 foods from each target in the ★★★ group. Diversity supports not only taste but also the microbiome response.
Risk management: The ⚠ marking is not a ban but a question of dosing. In IBS / SIBO cases, titrate the items in list 8 starting at 5 g/day, gradually increasing over 2—4 weeks.
Updating with new evidence: The tables are dynamic — as new RCTs appear, the evidence levels are updated. They reflect the state of the v1.5 edition as of 2026-06-02.
The classification was carried out according to strict audit criteria developed during the internal review of Food Sources v1.5:
- 7a) Journal-attribution accuracy: PMC, Wikipedia and other indexing / popular sources are NOT considered peer-reviewed sources.
- 7b) Context match: the cited RCT applies to the food-specific form being examined (e.g. chicory inulin ≠ artichoke VLCI, garlic ≠ black garlic).
- 7c) Prohibition of non-peer-reviewed sources: only peer-reviewed journals, EFSA / EMA / Cochrane / WHO / FDA official documents may be included.
- 7d) Year consistency: the year in the text and the reference number must match.
- 7e) Meta vs RCT disambiguation: a meta-analysis cannot be cited as an individual RCT.
If a statement does not meet the above criteria, the food is omitted from the list or assigned a lower evidence level. In the full review of the 196 chapters, 33 genuine factual errors and 54 attribution inconsistencies were corrected for the v1.5 version (see `SCI-REVIEW-FIXES.md`).

